Trial intelligence / Profile preview

Botulift vs Botox for Glabellar Wrinkles

NCT01180348Phase 3Completed

Sponsor
Azidus Laboratories Limited
Start
Aug 2011
Primary completion
Oct 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of neuronox in glabellar lines, sponsored by Azidus Laboratories Limited. Started Aug 2011; status: completed.

02

Drugs

neuronox
03

Conditions

glabellar lines

Beyond the preview

Go deeper on NCT01180348.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01180348.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call